GEODE CAPITAL MANAGEMENT, LLC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 68 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$2,709,000
+0.6%
1,472,753
+15.4%
0.00%0.0%
Q4 2017$2,692,000
+20.9%
1,276,263
+27.8%
0.00%0.0%
Q3 2017$2,227,000
+31.7%
998,697
+1.6%
0.00%0.0%
Q2 2017$1,691,000
-25.5%
983,244
+6.9%
0.00%0.0%
Q1 2017$2,271,000
+74.6%
919,446
+6.0%
0.00%0.0%
Q4 2016$1,301,000
-29.1%
867,504
+21.1%
0.00%0.0%
Q3 2016$1,834,000
+73.7%
716,449
+3.8%
0.00%0.0%
Q2 2016$1,056,000
-21.5%
690,206
+1.5%
0.00%0.0%
Q1 2016$1,346,000
-35.5%
680,280
+0.6%
0.00%0.0%
Q4 2015$2,088,000
+1.2%
676,017
+9.7%
0.00%0.0%
Q3 2015$2,063,000
-3.2%
616,034
+7.2%
0.00%0.0%
Q2 2015$2,132,000
+6.0%
574,675
+6.0%
0.00%0.0%
Q1 2015$2,011,000
+3.6%
542,277
+23.2%
0.00%0.0%
Q4 2014$1,941,000
+98.3%
440,211
+3.0%
0.00%0.0%
Q3 2014$979,000
-9.6%
427,570
+14.5%
0.00%0.0%
Q2 2014$1,083,000
-19.7%
373,463
+12.9%
0.00%0.0%
Q1 2014$1,349,000
+10.8%
330,770
+25.7%
0.00%0.0%
Q4 2013$1,218,000
+314.3%
263,234
+56.0%
0.00%
Q3 2013$294,000
+167.3%
168,741
+0.1%
0.00%
Q2 2013$110,000168,5810.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 474,609$626,0000.55%
Kassirer Asset Management Corp 325,800$430,0000.28%
CORRADO ADVISORS, LLC 104,850$138,0000.08%
Artal Group S.A. 2,750,000$3,630,0000.08%
ROPES WEALTH ADVISORS LLC 100,000$132,0000.04%
MYCIO WEALTH PARTNERS, LLC 246,527$325,0000.03%
Palo Alto Investors LP 616,355$814,0000.03%
HOLLENCREST CAPITAL MANAGEMENT 172,570$228,0000.03%
LAU ASSOCIATES LLC 26,713$35,0000.02%
NATIXIS 3,438,529$4,539,0000.02%
View complete list of IDERA PHARMACEUTICALS INC shareholders